Edgewise Therapeutics, Inc. SEC filings EWTX
Edgewise Therapeutics, Inc. has 421 filings in SEC EDGAR's recent list, going back to Sep 26, 2019. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K/A | Amended current report | Jul 16, 2026 | Jul 10, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Jul 13, 2026 | Jul 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 1, 2026 | May 31, 2026 |
| S-8 | Employee stock plan registration | May 7, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 4, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Nov 20, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 26, 2025 | Jun 26, 2025 |
| DEFA14A | Additional proxy material | May 14, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 13, 2025 |
| 424B5 | Prospectus supplement | Apr 2, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 2, 2025 | Apr 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 2, 2025 | Apr 2, 2025 |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 22, 2025 | Jan 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| S-8 | Employee stock plan registration | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 12, 2024 | Aug 10, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 11, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
May 10, 2024 | May 10, 2024 |
| S-3ASR | Automatic shelf registration | May 10, 2024 | — |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| DEFA14A | Additional proxy material | May 7, 2024 | — |
| 8-K |
Current report
Officer or director change
|
May 7, 2024 | May 6, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 7, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2024 | Jun 7, 2024 |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 22, 2024 | Feb 22, 2024 |
| 424B5 | Prospectus supplement | Jan 19, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 19, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 19, 2024 | Jan 19, 2024 |
| S-3MEF | Filing | Jan 19, 2024 | — |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 14, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Jun 22, 2023 | Jun 19, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jun 16, 2023 | Jun 15, 2023 |
| 424B5 | Prospectus supplement | Jun 16, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2023 | Jun 9, 2023 |
| S-8 | Employee stock plan registration | May 11, 2023 | — |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 6, 2023 | Mar 2, 2023 |
| 10-K | Annual report | Feb 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Material agreement
|
Sep 14, 2022 | Sep 13, 2022 |
| 424B5 | Prospectus supplement | Sep 14, 2022 | — |
| 424B5 | Prospectus supplement | Sep 13, 2022 | — |
| 8-K |
Current report
Other events
|
Sep 13, 2022 | Sep 7, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2022 | Jun 23, 2022 |
| 10-Q | Quarterly report | May 11, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| EFFECT | Filing | May 5, 2022 | — |
| 424B5 | Prospectus supplement | May 5, 2022 | — |
| CORRESP | Letter to the SEC | May 3, 2022 | — |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 23, 2022 |
| UPLOAD | Letter from the SEC | Apr 8, 2022 | — |
| S-3 | Shelf registration | Apr 1, 2022 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| 10-K | Annual report | Feb 24, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2022 | Jan 5, 2022 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2021 | Oct 28, 2021 |
| 10-Q | Quarterly report | Aug 9, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 30, 2021 | Mar 30, 2021 |
| S-8 | Employee stock plan registration | Mar 26, 2021 | — |
| 424B4 | Prospectus | Mar 26, 2021 | — |
| EFFECT | Filing | Mar 25, 2021 | — |
| S-1MEF | Filing | Mar 25, 2021 | — |
| CERT | Filing | Mar 25, 2021 | — |
| S-1/A | Amended registration statement | Mar 24, 2021 | — |
| CORRESP | Letter to the SEC | Mar 22, 2021 | — |
| CORRESP | Letter to the SEC | Mar 22, 2021 | — |
| S-1/A | Amended registration statement | Mar 22, 2021 | — |
| 8-A12B | Filing | Mar 17, 2021 | — |
| CORRESP | Letter to the SEC | Mar 8, 2021 | — |
| S-1 | Registration statement | Mar 5, 2021 | — |
| DRS/A | Filing | Mar 2, 2021 | — |
| DRS/A | Filing | Jan 25, 2021 | — |
| DRSLTR | Filing | Jan 22, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2021 | — |
| DRS | Filing | Dec 18, 2020 | — |
| D | Filing | Dec 10, 2020 | — |
| D | Filing | Sep 26, 2019 | — |
Showing 127 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EWTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boulder, CO
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1710072
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.